Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
Serena Omo‐Lamai(University of Pennsylvania), Marco E. Zamora(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Alina D. Peshkova(Kazan Federal University), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Liam S. Chase(University of Pennsylvania), Jia Nong(University of Pennsylvania), Oscar A. Marcos‐Contreras(University of Pennsylvania), Manthan N. Patel(Translational Therapeutics (United States)), Jichuan Wu(University of Pennsylvania), Zhicheng Wang(Central South University), Eno‐Obong Essien(Translational Therapeutics (United States)), Jilian R. Melamed(Kaiser Permanente), Aparajeeta Majumder(Translational Therapeutics (United States))
Cited by 99
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581